5.4972

3.96% 0.2072

Olema Pharmaceuticals Inc (OLMA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$5.29

Offen:

$5.35

24-Stunden-Volumen:

200.29K

Relative Volume:

0.22

Marktkapitalisierung:

$335.65M

Einnahmen:

Nettoeinkommen (Verlust:

$-96.66M

KGV:

-2.5568

EPS:

-2.15

Netto-Cashflow:

$-83.73M

1W Leistung:

+12.00%

1M Leistung:

+65.14%

6M Leistung:

-52.67%

1J Leistung:

-45.39%

1-Tages-Spanne:

$5.33

$5.60

1-Wochen-Bereich:

$4.66

$5.60

52-Wochen-Spanne:

$2.86

$16.62

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Firmenname

Olema Pharmaceuticals Inc

Sektor

Healthcare (1153)

Branche

Biotechnology (662)

Telefon

(415) 651-3316

Adresse

780 BRANNAN STREET, SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-18

Neueste SEC-Einreichungen

OLMA's Discussions on Twitter

Vergleichen Sie OLMA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OLMA Olema Pharmaceuticals Inc	5.495	335.65M	0	-96.66M	-83.73M	-2.15
VRTX Vertex Pharmaceuticals Inc	499.50	126.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	609.55	65.06B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	646.58	37.54B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	259.32	32.56B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	255.32	26.40B	3.81B	-644.79M	-669.77M	-6.24

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-04-02	Eingeleitet	Goldman	Buy
2024-01-30	Eingeleitet	Citigroup	Buy
2023-07-21	Eingeleitet	Oppenheimer	Outperform
2023-05-05	Eingeleitet	CapitalOne	Overweight
2023-02-22	Eingeleitet	Credit Suisse	Outperform
2022-07-06	Fortgesetzt	Canaccord Genuity	Buy
2022-06-09	Hochstufung	H.C. Wainwright	Neutral → Buy
2022-02-28	Eingeleitet	H.C. Wainwright	Neutral
2021-12-07	Fortgesetzt	Cowen	Outperform
2020-12-14	Eingeleitet	Canaccord Genuity	Buy
2020-12-14	Eingeleitet	Cowen	Outperform
2020-12-14	Eingeleitet	JP Morgan	Overweight
2020-12-14	Eingeleitet	Jefferies	Buy

Alle ansehen

Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten

04:08 AM

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Legal & General Group Plc - Defense World

04:08 AM

May 01, 2025

A look into Olema Pharmaceuticals Inc (OLMA)’s deeper side - Sete News

May 01, 2025

Renaissance Technologies LLC Has $917,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

May 01, 2025

Apr 30, 2025

Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight - GlobeNewswire Inc.

Apr 30, 2025

Can you now get a good deal on Olema Pharmaceuticals Inc’s shares? - uspostnews.com

Apr 30, 2025

Olema Pharmaceuticals' (OLMA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Apr 30, 2025

Apr 29, 2025

Walleye Capital LLC Invests $391,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Apr 29, 2025

Financial Snapshot: Analyzing Olema Pharmaceuticals Inc (OLMA)’s Key Ratio Metrics - DWinneX

Apr 29, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 29, 2025

Olema Pharmaceuticals’ (OLMA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 29, 2025

Apr 28, 2025

Market Recap Check: Olema Pharmaceuticals Inc (OLMA)’s Negative Finish at 3.76, Up/Down -8.52 - DWinneX

Apr 28, 2025

Silverarc Capital Management LLC Reduces Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Apr 28, 2025

Apr 27, 2025

Avoro Capital Advisors LLC Takes $9.63 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Apr 27, 2025

Apr 26, 2025

Geode Capital Management LLC Decreases Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Apr 26, 2025

Bain Capital Life Sciences Investors LLC Invests $43.55 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Apr 26, 2025

Apr 25, 2025

Olema Pharmaceuticals Says OP-3136 Molecule Shows Anti-Tumor Activity in Preclinical Models - marketscreener.com

Apr 25, 2025

Olema Oncology Announces New Preclinical Data for OP-3136 - GlobeNewswire

Apr 25, 2025

Cancer Breakthrough: New Drug OP-3136 Achieves 28-Day Tumor Regression in Multiple Cancer Types - Stock Titan

Apr 25, 2025

Apr 24, 2025

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat

Apr 24, 2025

Financial Analysis: Olema Pharmaceuticals Inc (OLMA)’s Ratios Unveil Key Insights - DWinneX

Apr 24, 2025

Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet - Yahoo Finance

Apr 24, 2025